Kinnate Biopharma Inc. (KNTE) Misses Q1 EPS by 2c

Kinnate Biopharma Inc. (NASDAQ: KNTE) reported Q1 EPS of ($0.73), $0.02 worse than the analyst estimate of ($0.71).

For earnings history and earnings-related data on Kinnate Biopharma Inc. (KNTE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15